nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—ABCB1—kidney cancer	0.217	1	CbGaD
Loratadine—ABCB1—Temsirolimus—kidney cancer	0.04	0.0671	CbGbCtD
Loratadine—KCNH2—Sunitinib—kidney cancer	0.0395	0.0664	CbGbCtD
Loratadine—CYP2D6—Temsirolimus—kidney cancer	0.0377	0.0633	CbGbCtD
Loratadine—CYP3A4—Everolimus—kidney cancer	0.0354	0.0596	CbGbCtD
Loratadine—CYP2C8—Pazopanib—kidney cancer	0.031	0.0521	CbGbCtD
Loratadine—CYP3A4—Temsirolimus—kidney cancer	0.0239	0.0402	CbGbCtD
Loratadine—CYP2C9—Capecitabine—kidney cancer	0.0226	0.0379	CbGbCtD
Loratadine—CYP2C8—Erlotinib—kidney cancer	0.0221	0.0372	CbGbCtD
Loratadine—ABCB1—Pazopanib—kidney cancer	0.021	0.0353	CbGbCtD
Loratadine—CYP2C8—Paclitaxel—kidney cancer	0.0203	0.034	CbGbCtD
Loratadine—CYP2D6—Pazopanib—kidney cancer	0.0198	0.0332	CbGbCtD
Loratadine—ABCB1—Dactinomycin—kidney cancer	0.0192	0.0323	CbGbCtD
Loratadine—CYP2C8—Sorafenib—kidney cancer	0.018	0.0302	CbGbCtD
Loratadine—ABCB1—Gemcitabine—kidney cancer	0.0152	0.0255	CbGbCtD
Loratadine—CYP2C19—Sorafenib—kidney cancer	0.0151	0.0254	CbGbCtD
Loratadine—ABCB1—Erlotinib—kidney cancer	0.015	0.0252	CbGbCtD
Loratadine—CYP2C9—Paclitaxel—kidney cancer	0.0141	0.0237	CbGbCtD
Loratadine—CYP2D6—Erlotinib—kidney cancer	0.0141	0.0237	CbGbCtD
Loratadine—ABCB1—Paclitaxel—kidney cancer	0.0137	0.023	CbGbCtD
Loratadine—CYP3A4—Pazopanib—kidney cancer	0.0126	0.0211	CbGbCtD
Loratadine—CYP2C9—Sorafenib—kidney cancer	0.0126	0.0211	CbGbCtD
Loratadine—ABCB1—Sorafenib—kidney cancer	0.0122	0.0205	CbGbCtD
Loratadine—ABCB1—Vinblastine—kidney cancer	0.012	0.0202	CbGbCtD
Loratadine—ABCB1—Vincristine—kidney cancer	0.0118	0.0199	CbGbCtD
Loratadine—CYP2D6—Sorafenib—kidney cancer	0.0115	0.0193	CbGbCtD
Loratadine—CYP2D6—Vinblastine—kidney cancer	0.0113	0.019	CbGbCtD
Loratadine—ABCB1—Sunitinib—kidney cancer	0.00987	0.0166	CbGbCtD
Loratadine—CYP3A4—Erlotinib—kidney cancer	0.00898	0.0151	CbGbCtD
Loratadine—CYP3A4—Paclitaxel—kidney cancer	0.00822	0.0138	CbGbCtD
Loratadine—ABCB1—Doxorubicin—kidney cancer	0.00739	0.0124	CbGbCtD
Loratadine—CYP3A4—Sorafenib—kidney cancer	0.0073	0.0123	CbGbCtD
Loratadine—CYP3A4—Vinblastine—kidney cancer	0.00721	0.0121	CbGbCtD
Loratadine—CYP3A4—Vincristine—kidney cancer	0.00708	0.0119	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—kidney cancer	0.00696	0.0117	CbGbCtD
Loratadine—CYP3A4—Sunitinib—kidney cancer	0.00591	0.00993	CbGbCtD
Loratadine—CYP3A4—Doxorubicin—kidney cancer	0.00443	0.00744	CbGbCtD
Loratadine—CYP2C19—urine—kidney cancer	0.000764	0.205	CbGeAlD
Loratadine—CYP2C9—urine—kidney cancer	0.000592	0.159	CbGeAlD
Loratadine—CYP3A4—urine—kidney cancer	0.000451	0.121	CbGeAlD
Loratadine—CYP2D6—urine—kidney cancer	0.000444	0.119	CbGeAlD
Loratadine—Constipation—Sunitinib—kidney cancer	0.000242	0.0014	CcSEcCtD
Loratadine—Immune system disorder—Paclitaxel—kidney cancer	0.000242	0.0014	CcSEcCtD
Loratadine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000241	0.00139	CcSEcCtD
Loratadine—Hypertension—Gemcitabine—kidney cancer	0.000241	0.00139	CcSEcCtD
Loratadine—Anaphylactic shock—Vincristine—kidney cancer	0.00024	0.00138	CcSEcCtD
Loratadine—Arrhythmia—Paclitaxel—kidney cancer	0.000239	0.00138	CcSEcCtD
Loratadine—Chest pain—Gemcitabine—kidney cancer	0.000237	0.00137	CcSEcCtD
Loratadine—Myalgia—Gemcitabine—kidney cancer	0.000237	0.00137	CcSEcCtD
Loratadine—Alopecia—Paclitaxel—kidney cancer	0.000237	0.00137	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000236	0.00136	CcSEcCtD
Loratadine—Nervous system disorder—Vincristine—kidney cancer	0.000235	0.00136	CcSEcCtD
Loratadine—Asthenia—Erlotinib—kidney cancer	0.000235	0.00136	CcSEcCtD
Loratadine—Discomfort—Gemcitabine—kidney cancer	0.000234	0.00135	CcSEcCtD
Loratadine—Diarrhoea—Vinblastine—kidney cancer	0.000233	0.00134	CcSEcCtD
Loratadine—Abdominal pain—Sorafenib—kidney cancer	0.000233	0.00134	CcSEcCtD
Loratadine—Body temperature increased—Sorafenib—kidney cancer	0.000233	0.00134	CcSEcCtD
Loratadine—Diarrhoea—Everolimus—kidney cancer	0.000232	0.00134	CcSEcCtD
Loratadine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000232	0.00134	CcSEcCtD
Loratadine—Hepatobiliary disease—Capecitabine—kidney cancer	0.000232	0.00134	CcSEcCtD
Loratadine—Fatigue—Dactinomycin—kidney cancer	0.000231	0.00133	CcSEcCtD
Loratadine—Epistaxis—Capecitabine—kidney cancer	0.000231	0.00133	CcSEcCtD
Loratadine—Pain—Dactinomycin—kidney cancer	0.000229	0.00132	CcSEcCtD
Loratadine—Tension—Paclitaxel—kidney cancer	0.000229	0.00132	CcSEcCtD
Loratadine—Dysgeusia—Paclitaxel—kidney cancer	0.000228	0.00132	CcSEcCtD
Loratadine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000227	0.00131	CcSEcCtD
Loratadine—Nervousness—Paclitaxel—kidney cancer	0.000227	0.00131	CcSEcCtD
Loratadine—Dizziness—Vinblastine—kidney cancer	0.000225	0.0013	CcSEcCtD
Loratadine—Dizziness—Everolimus—kidney cancer	0.000224	0.00129	CcSEcCtD
Loratadine—Body temperature increased—Sunitinib—kidney cancer	0.000224	0.00129	CcSEcCtD
Loratadine—Abdominal pain—Sunitinib—kidney cancer	0.000224	0.00129	CcSEcCtD
Loratadine—Diarrhoea—Erlotinib—kidney cancer	0.000224	0.00129	CcSEcCtD
Loratadine—Hypotension—Vincristine—kidney cancer	0.000224	0.00129	CcSEcCtD
Loratadine—Nervous system disorder—Gemcitabine—kidney cancer	0.000223	0.00129	CcSEcCtD
Loratadine—Feeling abnormal—Dactinomycin—kidney cancer	0.000221	0.00128	CcSEcCtD
Loratadine—Skin disorder—Gemcitabine—kidney cancer	0.000221	0.00127	CcSEcCtD
Loratadine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000219	0.00127	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000218	0.00126	CcSEcCtD
Loratadine—Pharyngitis—Capecitabine—kidney cancer	0.000218	0.00126	CcSEcCtD
Loratadine—Increased appetite—Doxorubicin—kidney cancer	0.000218	0.00126	CcSEcCtD
Loratadine—Insomnia—Vincristine—kidney cancer	0.000217	0.00125	CcSEcCtD
Loratadine—Vomiting—Vinblastine—kidney cancer	0.000217	0.00125	CcSEcCtD
Loratadine—Dizziness—Erlotinib—kidney cancer	0.000217	0.00125	CcSEcCtD
Loratadine—Ill-defined disorder—Paclitaxel—kidney cancer	0.000216	0.00125	CcSEcCtD
Loratadine—Vomiting—Everolimus—kidney cancer	0.000216	0.00124	CcSEcCtD
Loratadine—Paraesthesia—Vincristine—kidney cancer	0.000215	0.00124	CcSEcCtD
Loratadine—Dermatitis bullous—Doxorubicin—kidney cancer	0.000214	0.00124	CcSEcCtD
Loratadine—Agitation—Paclitaxel—kidney cancer	0.000214	0.00124	CcSEcCtD
Loratadine—Rash—Everolimus—kidney cancer	0.000214	0.00123	CcSEcCtD
Loratadine—Dermatitis—Everolimus—kidney cancer	0.000214	0.00123	CcSEcCtD
Loratadine—Headache—Vinblastine—kidney cancer	0.000213	0.00123	CcSEcCtD
Loratadine—Angioedema—Paclitaxel—kidney cancer	0.000213	0.00123	CcSEcCtD
Loratadine—Headache—Everolimus—kidney cancer	0.000213	0.00123	CcSEcCtD
Loratadine—Hypotension—Gemcitabine—kidney cancer	0.000213	0.00123	CcSEcCtD
Loratadine—Abdominal pain—Dactinomycin—kidney cancer	0.000212	0.00122	CcSEcCtD
Loratadine—Body temperature increased—Dactinomycin—kidney cancer	0.000212	0.00122	CcSEcCtD
Loratadine—Asthenia—Sorafenib—kidney cancer	0.000211	0.00122	CcSEcCtD
Loratadine—Malaise—Paclitaxel—kidney cancer	0.00021	0.00121	CcSEcCtD
Loratadine—Syncope—Paclitaxel—kidney cancer	0.000209	0.00121	CcSEcCtD
Loratadine—Lethargy—Doxorubicin—kidney cancer	0.000209	0.00121	CcSEcCtD
Loratadine—Vomiting—Erlotinib—kidney cancer	0.000208	0.0012	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000207	0.0012	CcSEcCtD
Loratadine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000207	0.00119	CcSEcCtD
Loratadine—Fatigue—Vincristine—kidney cancer	0.000207	0.00119	CcSEcCtD
Loratadine—Rash—Erlotinib—kidney cancer	0.000206	0.00119	CcSEcCtD
Loratadine—Dermatitis—Erlotinib—kidney cancer	0.000206	0.00119	CcSEcCtD
Loratadine—Palpitations—Paclitaxel—kidney cancer	0.000206	0.00119	CcSEcCtD
Loratadine—Insomnia—Gemcitabine—kidney cancer	0.000206	0.00119	CcSEcCtD
Loratadine—Headache—Erlotinib—kidney cancer	0.000205	0.00118	CcSEcCtD
Loratadine—Tinnitus—Capecitabine—kidney cancer	0.000205	0.00118	CcSEcCtD
Loratadine—Loss of consciousness—Paclitaxel—kidney cancer	0.000205	0.00118	CcSEcCtD
Loratadine—Constipation—Vincristine—kidney cancer	0.000205	0.00118	CcSEcCtD
Loratadine—Pain—Vincristine—kidney cancer	0.000205	0.00118	CcSEcCtD
Loratadine—Paraesthesia—Gemcitabine—kidney cancer	0.000204	0.00118	CcSEcCtD
Loratadine—Cough—Paclitaxel—kidney cancer	0.000204	0.00117	CcSEcCtD
Loratadine—Asthenia—Sunitinib—kidney cancer	0.000203	0.00117	CcSEcCtD
Loratadine—Nausea—Vinblastine—kidney cancer	0.000202	0.00117	CcSEcCtD
Loratadine—Somnolence—Gemcitabine—kidney cancer	0.000202	0.00117	CcSEcCtD
Loratadine—Nausea—Everolimus—kidney cancer	0.000202	0.00116	CcSEcCtD
Loratadine—Diarrhoea—Sorafenib—kidney cancer	0.000202	0.00116	CcSEcCtD
Loratadine—Hypertension—Paclitaxel—kidney cancer	0.000201	0.00116	CcSEcCtD
Loratadine—Immune system disorder—Capecitabine—kidney cancer	0.000199	0.00115	CcSEcCtD
Loratadine—Chest pain—Paclitaxel—kidney cancer	0.000199	0.00115	CcSEcCtD
Loratadine—Myalgia—Paclitaxel—kidney cancer	0.000199	0.00115	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000197	0.00114	CcSEcCtD
Loratadine—Arrhythmia—Capecitabine—kidney cancer	0.000196	0.00113	CcSEcCtD
Loratadine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000196	0.00113	CcSEcCtD
Loratadine—Discomfort—Paclitaxel—kidney cancer	0.000196	0.00113	CcSEcCtD
Loratadine—Fatigue—Gemcitabine—kidney cancer	0.000196	0.00113	CcSEcCtD
Loratadine—Gastrointestinal pain—Vincristine—kidney cancer	0.000196	0.00113	CcSEcCtD
Loratadine—Dizziness—Sorafenib—kidney cancer	0.000195	0.00112	CcSEcCtD
Loratadine—Constipation—Gemcitabine—kidney cancer	0.000194	0.00112	CcSEcCtD
Loratadine—Pain—Gemcitabine—kidney cancer	0.000194	0.00112	CcSEcCtD
Loratadine—Nausea—Erlotinib—kidney cancer	0.000194	0.00112	CcSEcCtD
Loratadine—Alopecia—Capecitabine—kidney cancer	0.000194	0.00112	CcSEcCtD
Loratadine—Dry mouth—Paclitaxel—kidney cancer	0.000194	0.00112	CcSEcCtD
Loratadine—Diarrhoea—Sunitinib—kidney cancer	0.000194	0.00112	CcSEcCtD
Loratadine—Asthenia—Dactinomycin—kidney cancer	0.000193	0.00111	CcSEcCtD
Loratadine—Anaphylactic shock—Paclitaxel—kidney cancer	0.00019	0.0011	CcSEcCtD
Loratadine—Body temperature increased—Vincristine—kidney cancer	0.00019	0.00109	CcSEcCtD
Loratadine—Abdominal pain—Vincristine—kidney cancer	0.00019	0.00109	CcSEcCtD
Loratadine—Dysgeusia—Capecitabine—kidney cancer	0.000188	0.00108	CcSEcCtD
Loratadine—Dizziness—Sunitinib—kidney cancer	0.000187	0.00108	CcSEcCtD
Loratadine—Feeling abnormal—Gemcitabine—kidney cancer	0.000187	0.00108	CcSEcCtD
Loratadine—Shock—Paclitaxel—kidney cancer	0.000187	0.00108	CcSEcCtD
Loratadine—Vomiting—Sorafenib—kidney cancer	0.000187	0.00108	CcSEcCtD
Loratadine—Abdominal pain upper—Doxorubicin—kidney cancer	0.000187	0.00108	CcSEcCtD
Loratadine—Nervous system disorder—Paclitaxel—kidney cancer	0.000187	0.00108	CcSEcCtD
Loratadine—Tachycardia—Paclitaxel—kidney cancer	0.000186	0.00107	CcSEcCtD
Loratadine—Rash—Sorafenib—kidney cancer	0.000186	0.00107	CcSEcCtD
Loratadine—Dermatitis—Sorafenib—kidney cancer	0.000186	0.00107	CcSEcCtD
Loratadine—Skin disorder—Paclitaxel—kidney cancer	0.000185	0.00107	CcSEcCtD
Loratadine—Headache—Sorafenib—kidney cancer	0.000185	0.00106	CcSEcCtD
Loratadine—Diarrhoea—Dactinomycin—kidney cancer	0.000184	0.00106	CcSEcCtD
Loratadine—Gastritis—Doxorubicin—kidney cancer	0.000181	0.00105	CcSEcCtD
Loratadine—Vomiting—Sunitinib—kidney cancer	0.00018	0.00104	CcSEcCtD
Loratadine—Body temperature increased—Gemcitabine—kidney cancer	0.00018	0.00104	CcSEcCtD
Loratadine—Rash—Sunitinib—kidney cancer	0.000179	0.00103	CcSEcCtD
Loratadine—Dermatitis—Sunitinib—kidney cancer	0.000179	0.00103	CcSEcCtD
Loratadine—KCNH2—renal system—kidney cancer	0.000178	0.0479	CbGeAlD
Loratadine—Hypotension—Paclitaxel—kidney cancer	0.000178	0.00103	CcSEcCtD
Loratadine—Ill-defined disorder—Capecitabine—kidney cancer	0.000178	0.00102	CcSEcCtD
Loratadine—Headache—Sunitinib—kidney cancer	0.000178	0.00102	CcSEcCtD
Loratadine—Nausea—Sorafenib—kidney cancer	0.000175	0.00101	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000173	0.001	CcSEcCtD
Loratadine—Malaise—Capecitabine—kidney cancer	0.000173	0.000996	CcSEcCtD
Loratadine—Insomnia—Paclitaxel—kidney cancer	0.000172	0.000994	CcSEcCtD
Loratadine—Asthenia—Vincristine—kidney cancer	0.000172	0.000992	CcSEcCtD
Loratadine—Syncope—Capecitabine—kidney cancer	0.000172	0.000991	CcSEcCtD
Loratadine—Paraesthesia—Paclitaxel—kidney cancer	0.000171	0.000987	CcSEcCtD
Loratadine—Vomiting—Dactinomycin—kidney cancer	0.000171	0.000984	CcSEcCtD
Loratadine—Somnolence—Paclitaxel—kidney cancer	0.000169	0.000977	CcSEcCtD
Loratadine—Palpitations—Capecitabine—kidney cancer	0.000169	0.000976	CcSEcCtD
Loratadine—Rash—Dactinomycin—kidney cancer	0.000169	0.000976	CcSEcCtD
Loratadine—Nausea—Sunitinib—kidney cancer	0.000168	0.000971	CcSEcCtD
Loratadine—Loss of consciousness—Capecitabine—kidney cancer	0.000168	0.000971	CcSEcCtD
Loratadine—Dyspepsia—Paclitaxel—kidney cancer	0.000168	0.000967	CcSEcCtD
Loratadine—Cough—Capecitabine—kidney cancer	0.000167	0.000964	CcSEcCtD
Loratadine—Hypertension—Capecitabine—kidney cancer	0.000165	0.000954	CcSEcCtD
Loratadine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000164	0.000948	CcSEcCtD
Loratadine—Fatigue—Paclitaxel—kidney cancer	0.000164	0.000947	CcSEcCtD
Loratadine—Diarrhoea—Vincristine—kidney cancer	0.000164	0.000946	CcSEcCtD
Loratadine—Pollakiuria—Doxorubicin—kidney cancer	0.000164	0.000944	CcSEcCtD
Loratadine—Asthenia—Gemcitabine—kidney cancer	0.000163	0.000941	CcSEcCtD
Loratadine—CYP2C8—renal system—kidney cancer	0.000163	0.0438	CbGeAlD
Loratadine—Myalgia—Capecitabine—kidney cancer	0.000163	0.00094	CcSEcCtD
Loratadine—Chest pain—Capecitabine—kidney cancer	0.000163	0.00094	CcSEcCtD
Loratadine—Constipation—Paclitaxel—kidney cancer	0.000163	0.000939	CcSEcCtD
Loratadine—Pain—Paclitaxel—kidney cancer	0.000163	0.000939	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000162	0.000934	CcSEcCtD
Loratadine—Discomfort—Capecitabine—kidney cancer	0.000161	0.000929	CcSEcCtD
Loratadine—KCNH2—cardiac atrium—kidney cancer	0.00016	0.0429	CbGeAlD
Loratadine—Dry mouth—Capecitabine—kidney cancer	0.000159	0.00092	CcSEcCtD
Loratadine—Nausea—Dactinomycin—kidney cancer	0.000159	0.00092	CcSEcCtD
Loratadine—Dizziness—Vincristine—kidney cancer	0.000159	0.000915	CcSEcCtD
Loratadine—Drowsiness—Doxorubicin—kidney cancer	0.000158	0.000911	CcSEcCtD
Loratadine—CYP2C8—kidney—kidney cancer	0.000158	0.0423	CbGeAlD
Loratadine—Feeling abnormal—Paclitaxel—kidney cancer	0.000157	0.000905	CcSEcCtD
Loratadine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000156	0.000898	CcSEcCtD
Loratadine—Diarrhoea—Gemcitabine—kidney cancer	0.000156	0.000898	CcSEcCtD
Loratadine—Shock—Capecitabine—kidney cancer	0.000154	0.000887	CcSEcCtD
Loratadine—Nervous system disorder—Capecitabine—kidney cancer	0.000153	0.000884	CcSEcCtD
Loratadine—Tachycardia—Capecitabine—kidney cancer	0.000153	0.00088	CcSEcCtD
Loratadine—Vomiting—Vincristine—kidney cancer	0.000152	0.000879	CcSEcCtD
Loratadine—Skin disorder—Capecitabine—kidney cancer	0.000152	0.000876	CcSEcCtD
Loratadine—Rash—Vincristine—kidney cancer	0.000151	0.000872	CcSEcCtD
Loratadine—Dermatitis—Vincristine—kidney cancer	0.000151	0.000871	CcSEcCtD
Loratadine—Abdominal pain—Paclitaxel—kidney cancer	0.000151	0.000868	CcSEcCtD
Loratadine—Body temperature increased—Paclitaxel—kidney cancer	0.000151	0.000868	CcSEcCtD
Loratadine—Headache—Vincristine—kidney cancer	0.00015	0.000867	CcSEcCtD
Loratadine—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000149	0.000862	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—kidney cancer	0.000149	0.000859	CcSEcCtD
Loratadine—Hypotension—Capecitabine—kidney cancer	0.000146	0.000842	CcSEcCtD
Loratadine—Vomiting—Gemcitabine—kidney cancer	0.000145	0.000834	CcSEcCtD
Loratadine—Rash—Gemcitabine—kidney cancer	0.000143	0.000827	CcSEcCtD
Loratadine—Dermatitis—Gemcitabine—kidney cancer	0.000143	0.000827	CcSEcCtD
Loratadine—Headache—Gemcitabine—kidney cancer	0.000142	0.000822	CcSEcCtD
Loratadine—Nausea—Vincristine—kidney cancer	0.000142	0.000822	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000142	0.000821	CcSEcCtD
Loratadine—Insomnia—Capecitabine—kidney cancer	0.000141	0.000815	CcSEcCtD
Loratadine—Pharyngitis—Doxorubicin—kidney cancer	0.000141	0.000812	CcSEcCtD
Loratadine—Paraesthesia—Capecitabine—kidney cancer	0.00014	0.00081	CcSEcCtD
Loratadine—Dyspepsia—Capecitabine—kidney cancer	0.000138	0.000794	CcSEcCtD
Loratadine—Asthenia—Paclitaxel—kidney cancer	0.000137	0.000788	CcSEcCtD
Loratadine—Nausea—Gemcitabine—kidney cancer	0.000135	0.000779	CcSEcCtD
Loratadine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000135	0.000778	CcSEcCtD
Loratadine—Fatigue—Capecitabine—kidney cancer	0.000135	0.000777	CcSEcCtD
Loratadine—Pain—Capecitabine—kidney cancer	0.000134	0.000771	CcSEcCtD
Loratadine—Constipation—Capecitabine—kidney cancer	0.000134	0.000771	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—kidney cancer	0.000132	0.000763	CcSEcCtD
Loratadine—Diarrhoea—Paclitaxel—kidney cancer	0.00013	0.000752	CcSEcCtD
Loratadine—Feeling abnormal—Capecitabine—kidney cancer	0.000129	0.000743	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—kidney cancer	0.000128	0.000739	CcSEcCtD
Loratadine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000128	0.000737	CcSEcCtD
Loratadine—Arrhythmia—Doxorubicin—kidney cancer	0.000127	0.000731	CcSEcCtD
Loratadine—Dizziness—Paclitaxel—kidney cancer	0.000126	0.000727	CcSEcCtD
Loratadine—Alopecia—Doxorubicin—kidney cancer	0.000125	0.000723	CcSEcCtD
Loratadine—Body temperature increased—Capecitabine—kidney cancer	0.000124	0.000713	CcSEcCtD
Loratadine—Abdominal pain—Capecitabine—kidney cancer	0.000124	0.000713	CcSEcCtD
Loratadine—Tension—Doxorubicin—kidney cancer	0.000121	0.000699	CcSEcCtD
Loratadine—Vomiting—Paclitaxel—kidney cancer	0.000121	0.000699	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—kidney cancer	0.000121	0.000697	CcSEcCtD
Loratadine—Rash—Paclitaxel—kidney cancer	0.00012	0.000693	CcSEcCtD
Loratadine—Dermatitis—Paclitaxel—kidney cancer	0.00012	0.000692	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—kidney cancer	0.00012	0.000692	CcSEcCtD
Loratadine—Headache—Paclitaxel—kidney cancer	0.000119	0.000688	CcSEcCtD
Loratadine—Ill-defined disorder—Doxorubicin—kidney cancer	0.000115	0.000661	CcSEcCtD
Loratadine—Agitation—Doxorubicin—kidney cancer	0.000113	0.000654	CcSEcCtD
Loratadine—Nausea—Paclitaxel—kidney cancer	0.000113	0.000653	CcSEcCtD
Loratadine—Asthenia—Capecitabine—kidney cancer	0.000112	0.000647	CcSEcCtD
Loratadine—Malaise—Doxorubicin—kidney cancer	0.000111	0.000642	CcSEcCtD
Loratadine—Syncope—Doxorubicin—kidney cancer	0.000111	0.000639	CcSEcCtD
Loratadine—CYP3A4—renal system—kidney cancer	0.00011	0.0297	CbGeAlD
Loratadine—Palpitations—Doxorubicin—kidney cancer	0.000109	0.000629	CcSEcCtD
Loratadine—CYP2D6—renal system—kidney cancer	0.000109	0.0292	CbGeAlD
Loratadine—Loss of consciousness—Doxorubicin—kidney cancer	0.000108	0.000626	CcSEcCtD
Loratadine—Cough—Doxorubicin—kidney cancer	0.000108	0.000621	CcSEcCtD
Loratadine—Diarrhoea—Capecitabine—kidney cancer	0.000107	0.000617	CcSEcCtD
Loratadine—CYP3A4—kidney—kidney cancer	0.000107	0.0287	CbGeAlD
Loratadine—Hypertension—Doxorubicin—kidney cancer	0.000107	0.000615	CcSEcCtD
Loratadine—CYP2D6—kidney—kidney cancer	0.000105	0.0282	CbGeAlD
Loratadine—Chest pain—Doxorubicin—kidney cancer	0.000105	0.000606	CcSEcCtD
Loratadine—Myalgia—Doxorubicin—kidney cancer	0.000105	0.000606	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000104	0.000602	CcSEcCtD
Loratadine—Discomfort—Doxorubicin—kidney cancer	0.000104	0.000599	CcSEcCtD
Loratadine—Dizziness—Capecitabine—kidney cancer	0.000103	0.000596	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—kidney cancer	0.000103	0.000593	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000101	0.000581	CcSEcCtD
Loratadine—Vomiting—Capecitabine—kidney cancer	9.94e-05	0.000573	CcSEcCtD
Loratadine—Shock—Doxorubicin—kidney cancer	9.91e-05	0.000572	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—kidney cancer	9.88e-05	0.00057	CcSEcCtD
Loratadine—Rash—Capecitabine—kidney cancer	9.85e-05	0.000568	CcSEcCtD
Loratadine—Dermatitis—Capecitabine—kidney cancer	9.84e-05	0.000568	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—kidney cancer	9.83e-05	0.000567	CcSEcCtD
Loratadine—Headache—Capecitabine—kidney cancer	9.79e-05	0.000565	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—kidney cancer	9.78e-05	0.000564	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—kidney cancer	9.41e-05	0.000543	CcSEcCtD
Loratadine—Nausea—Capecitabine—kidney cancer	9.28e-05	0.000536	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	9.18e-05	0.000529	CcSEcCtD
Loratadine—Insomnia—Doxorubicin—kidney cancer	9.11e-05	0.000526	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—kidney cancer	9.05e-05	0.000522	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—kidney cancer	8.96e-05	0.000517	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—kidney cancer	8.87e-05	0.000512	CcSEcCtD
Loratadine—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.7e-05	0.000502	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—kidney cancer	8.68e-05	0.000501	CcSEcCtD
Loratadine—Constipation—Doxorubicin—kidney cancer	8.61e-05	0.000497	CcSEcCtD
Loratadine—Pain—Doxorubicin—kidney cancer	8.61e-05	0.000497	CcSEcCtD
Loratadine—ABCB1—nephron tubule—kidney cancer	8.6e-05	0.0231	CbGeAlD
Loratadine—Feeling abnormal—Doxorubicin—kidney cancer	8.3e-05	0.000479	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—kidney cancer	8.24e-05	0.000475	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—kidney cancer	7.96e-05	0.000459	CcSEcCtD
Loratadine—Body temperature increased—Doxorubicin—kidney cancer	7.96e-05	0.000459	CcSEcCtD
Loratadine—ABCB1—renal system—kidney cancer	7.82e-05	0.021	CbGeAlD
Loratadine—ABCB1—kidney—kidney cancer	7.56e-05	0.0203	CbGeAlD
Loratadine—ABCB1—cortex of kidney—kidney cancer	7.36e-05	0.0198	CbGeAlD
Loratadine—Asthenia—Doxorubicin—kidney cancer	7.23e-05	0.000417	CcSEcCtD
Loratadine—ABCB1—gonad—kidney cancer	7.01e-05	0.0188	CbGeAlD
Loratadine—Diarrhoea—Doxorubicin—kidney cancer	6.89e-05	0.000398	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—kidney cancer	6.66e-05	0.000384	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—kidney cancer	6.4e-05	0.00037	CcSEcCtD
Loratadine—Rash—Doxorubicin—kidney cancer	6.35e-05	0.000366	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—kidney cancer	6.35e-05	0.000366	CcSEcCtD
Loratadine—Headache—Doxorubicin—kidney cancer	6.31e-05	0.000364	CcSEcCtD
Loratadine—Nausea—Doxorubicin—kidney cancer	5.98e-05	0.000345	CcSEcCtD
Loratadine—CYP3A4—Metabolism—ACY1—kidney cancer	7.34e-06	0.000688	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—FH—kidney cancer	7.23e-06	0.000678	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APRT—kidney cancer	7.23e-06	0.000678	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GPC3—kidney cancer	7.22e-06	0.000677	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CA2—kidney cancer	7.19e-06	0.000674	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—SLC5A3—kidney cancer	7.18e-06	0.000673	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PGK1—kidney cancer	7.18e-06	0.000673	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APRT—kidney cancer	7.17e-06	0.000672	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—FH—kidney cancer	7.17e-06	0.000672	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	7.15e-06	0.000671	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	7.04e-06	0.000661	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—LDHB—kidney cancer	7.04e-06	0.00066	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CA2—kidney cancer	7.02e-06	0.000658	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	7.01e-06	0.000658	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALAD—kidney cancer	7.01e-06	0.000657	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	7.01e-06	0.000657	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ST3GAL2—kidney cancer	6.84e-06	0.000641	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALAD—kidney cancer	6.84e-06	0.000641	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.8e-06	0.000638	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GPC3—kidney cancer	6.8e-06	0.000638	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GPC3—kidney cancer	6.74e-06	0.000632	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	6.69e-06	0.000627	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALDH1A1—kidney cancer	6.69e-06	0.000627	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ST3GAL2—kidney cancer	6.68e-06	0.000626	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	6.68e-06	0.000626	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	6.62e-06	0.000621	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CA2—kidney cancer	6.61e-06	0.00062	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	6.57e-06	0.000616	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CASP2—kidney cancer	6.56e-06	0.000615	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKAP13—kidney cancer	6.56e-06	0.000615	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CA2—kidney cancer	6.56e-06	0.000615	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALDH1A1—kidney cancer	6.53e-06	0.000612	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	6.46e-06	0.000605	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALAD—kidney cancer	6.45e-06	0.000604	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PGK1—kidney cancer	6.41e-06	0.000601	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SLC5A3—kidney cancer	6.41e-06	0.000601	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALAD—kidney cancer	6.39e-06	0.000599	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	6.29e-06	0.00059	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—LDHB—kidney cancer	6.29e-06	0.000589	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PGK1—kidney cancer	6.26e-06	0.000587	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SLC5A3—kidney cancer	6.26e-06	0.000587	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PDHB—kidney cancer	6.24e-06	0.000585	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ST3GAL2—kidney cancer	6.24e-06	0.000585	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—POMC—kidney cancer	6.22e-06	0.000583	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	6.15e-06	0.000577	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—LDHB—kidney cancer	6.13e-06	0.000575	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CA9—kidney cancer	6.11e-06	0.000572	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	6.1e-06	0.000572	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GRB7—kidney cancer	6e-06	0.000562	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.97e-06	0.00056	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PGK1—kidney cancer	5.9e-06	0.000553	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SLC5A3—kidney cancer	5.9e-06	0.000553	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CCBL1—kidney cancer	5.87e-06	0.00055	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PGK1—kidney cancer	5.84e-06	0.000548	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SLC5A3—kidney cancer	5.84e-06	0.000548	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.83e-06	0.000547	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—LDHB—kidney cancer	5.78e-06	0.000542	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—LDHB—kidney cancer	5.73e-06	0.000537	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ITPR2—kidney cancer	5.58e-06	0.000523	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	5.52e-06	0.000517	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CA9—kidney cancer	5.45e-06	0.000511	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	5.37e-06	0.000503	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.33e-06	0.000499	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CA9—kidney cancer	5.32e-06	0.000499	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	5.25e-06	0.000492	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CRABP1—kidney cancer	5.19e-06	0.000487	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPAT—kidney cancer	5.09e-06	0.000477	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GLIPR1—kidney cancer	5.09e-06	0.000477	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CTNNA1—kidney cancer	5.06e-06	0.000474	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EIF4EBP1—kidney cancer	5.03e-06	0.000471	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HSPB1—kidney cancer	5.03e-06	0.000471	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CA9—kidney cancer	5.01e-06	0.00047	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CA9—kidney cancer	4.97e-06	0.000466	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.96e-06	0.000465	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.86e-06	0.000455	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ITPR2—kidney cancer	4.83e-06	0.000453	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—FH—kidney cancer	4.73e-06	0.000443	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APRT—kidney cancer	4.73e-06	0.000443	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ANXA1—kidney cancer	4.67e-06	0.000438	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TSC1—kidney cancer	4.67e-06	0.000438	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PSMD7—kidney cancer	4.67e-06	0.000438	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CRABP1—kidney cancer	4.63e-06	0.000434	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.56e-06	0.000427	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FLT1—kidney cancer	4.53e-06	0.000424	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CRABP1—kidney cancer	4.52e-06	0.000424	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.45e-06	0.000417	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GPC3—kidney cancer	4.45e-06	0.000417	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.41e-06	0.000413	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTT1—kidney cancer	4.4e-06	0.000413	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ACHE—kidney cancer	4.4e-06	0.000413	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CA2—kidney cancer	4.32e-06	0.000405	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ITPR2—kidney cancer	4.31e-06	0.000404	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—POMC—kidney cancer	4.27e-06	0.0004	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CRABP1—kidney cancer	4.26e-06	0.0004	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CRABP1—kidney cancer	4.23e-06	0.000396	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALAD—kidney cancer	4.21e-06	0.000395	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ITPR2—kidney cancer	4.2e-06	0.000394	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PAK1—kidney cancer	4.2e-06	0.000393	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JUNB—kidney cancer	4.2e-06	0.000393	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—SCARB1—kidney cancer	4.17e-06	0.000391	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS1—kidney cancer	4.12e-06	0.000387	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	4.11e-06	0.000386	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PSMD7—kidney cancer	4.04e-06	0.000379	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	4.02e-06	0.000377	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.97e-06	0.000372	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ITPR2—kidney cancer	3.96e-06	0.000372	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTT1—kidney cancer	3.93e-06	0.000368	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ACHE—kidney cancer	3.93e-06	0.000368	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ITPR2—kidney cancer	3.93e-06	0.000368	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—POMC—kidney cancer	3.88e-06	0.000363	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.85e-06	0.000361	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PGK1—kidney cancer	3.85e-06	0.000361	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTT1—kidney cancer	3.83e-06	0.00036	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ACHE—kidney cancer	3.83e-06	0.00036	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—BCHE—kidney cancer	3.83e-06	0.00036	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—SLC5A5—kidney cancer	3.79e-06	0.000355	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LDHB—kidney cancer	3.78e-06	0.000354	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SCARB1—kidney cancer	3.72e-06	0.000349	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS1—kidney cancer	3.68e-06	0.000345	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.66e-06	0.000343	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SCARB1—kidney cancer	3.63e-06	0.00034	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.62e-06	0.00034	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTT1—kidney cancer	3.61e-06	0.000339	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ACHE—kidney cancer	3.61e-06	0.000339	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PSMD7—kidney cancer	3.61e-06	0.000338	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS1—kidney cancer	3.59e-06	0.000337	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ACHE—kidney cancer	3.58e-06	0.000336	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTT1—kidney cancer	3.58e-06	0.000336	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.55e-06	0.000333	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PSMD7—kidney cancer	3.52e-06	0.00033	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF2—kidney cancer	3.43e-06	0.000322	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—BCHE—kidney cancer	3.42e-06	0.000321	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SCARB1—kidney cancer	3.42e-06	0.000321	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN2B—kidney cancer	3.42e-06	0.00032	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SCARB1—kidney cancer	3.39e-06	0.000318	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS1—kidney cancer	3.39e-06	0.000317	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SLC5A5—kidney cancer	3.38e-06	0.000317	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS1—kidney cancer	3.36e-06	0.000315	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—BCHE—kidney cancer	3.34e-06	0.000313	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PSMD7—kidney cancer	3.32e-06	0.000311	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF1R—kidney cancer	3.32e-06	0.000311	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SLC5A5—kidney cancer	3.3e-06	0.000309	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PSMD7—kidney cancer	3.29e-06	0.000309	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CA9—kidney cancer	3.28e-06	0.000307	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SLC2A1—kidney cancer	3.26e-06	0.000306	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—RAF1—kidney cancer	3.2e-06	0.0003	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SLC2A1—kidney cancer	3.19e-06	0.000299	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.17e-06	0.000297	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—IL2—kidney cancer	3.16e-06	0.000296	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—BCHE—kidney cancer	3.15e-06	0.000295	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—BCHE—kidney cancer	3.12e-06	0.000293	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SLC5A5—kidney cancer	3.11e-06	0.000292	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.09e-06	0.00029	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SLC5A5—kidney cancer	3.08e-06	0.000289	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTP1—kidney cancer	3.05e-06	0.000286	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.04e-06	0.000285	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SLC2A1—kidney cancer	3e-06	0.000282	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.98e-06	0.000279	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.89e-06	0.000271	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ABCB1—kidney cancer	2.89e-06	0.000271	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL2—kidney cancer	2.87e-06	0.000269	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTM1—kidney cancer	2.8e-06	0.000263	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CRABP1—kidney cancer	2.79e-06	0.000261	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.76e-06	0.000259	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HIF1A—kidney cancer	2.73e-06	0.000256	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TSC2—kidney cancer	2.72e-06	0.000255	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTP1—kidney cancer	2.72e-06	0.000255	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTP1—kidney cancer	2.66e-06	0.000249	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.66e-06	0.000249	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KDR—kidney cancer	2.61e-06	0.000245	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ITPR2—kidney cancer	2.59e-06	0.000243	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ABCB1—kidney cancer	2.58e-06	0.000242	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.52e-06	0.000236	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTP1—kidney cancer	2.5e-06	0.000235	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTM1—kidney cancer	2.5e-06	0.000235	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTP1—kidney cancer	2.48e-06	0.000233	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTM1—kidney cancer	2.44e-06	0.000229	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KIT—kidney cancer	2.41e-06	0.000226	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APC—kidney cancer	2.41e-06	0.000226	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.37e-06	0.000222	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ABCB1—kidney cancer	2.37e-06	0.000222	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTT1—kidney cancer	2.36e-06	0.000222	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ACHE—kidney cancer	2.36e-06	0.000222	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ABCB1—kidney cancer	2.35e-06	0.00022	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP1A1—kidney cancer	2.32e-06	0.000217	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MAPK3—kidney cancer	2.3e-06	0.000216	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTM1—kidney cancer	2.3e-06	0.000216	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—POMC—kidney cancer	2.29e-06	0.000215	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTM1—kidney cancer	2.28e-06	0.000214	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BRAF—kidney cancer	2.26e-06	0.000212	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SCARB1—kidney cancer	2.24e-06	0.00021	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS1—kidney cancer	2.21e-06	0.000208	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MAPK1—kidney cancer	2.19e-06	0.000206	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.18e-06	0.000205	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.18e-06	0.000205	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PSMD7—kidney cancer	2.17e-06	0.000204	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.16e-06	0.000203	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	2.09e-06	0.000196	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—KRAS—kidney cancer	2.07e-06	0.000194	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—BCHE—kidney cancer	2.06e-06	0.000193	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.03e-06	0.000191	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—POMC—kidney cancer	1.98e-06	0.000186	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.96e-06	0.000184	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.95e-06	0.000183	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	1.9e-06	0.000178	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RAF1—kidney cancer	1.89e-06	0.000177	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RELA—kidney cancer	1.88e-06	0.000176	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ERBB2—kidney cancer	1.87e-06	0.000175	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MTOR—kidney cancer	1.84e-06	0.000173	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.78e-06	0.000167	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—POMC—kidney cancer	1.77e-06	0.000166	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	1.73e-06	0.000162	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—POMC—kidney cancer	1.73e-06	0.000162	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL2—kidney cancer	1.69e-06	0.000159	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCND1—kidney cancer	1.65e-06	0.000155	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JUN—kidney cancer	1.65e-06	0.000154	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTP1—kidney cancer	1.64e-06	0.000154	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	1.63e-06	0.000153	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—POMC—kidney cancer	1.63e-06	0.000153	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—POMC—kidney cancer	1.61e-06	0.000151	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTEN—kidney cancer	1.59e-06	0.000149	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS2—kidney cancer	1.58e-06	0.000148	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCB1—kidney cancer	1.55e-06	0.000145	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTM1—kidney cancer	1.5e-06	0.000141	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—kidney cancer	1.44e-06	0.000135	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.43e-06	0.000134	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS2—kidney cancer	1.41e-06	0.000132	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTEN—kidney cancer	1.38e-06	0.000129	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS2—kidney cancer	1.38e-06	0.000129	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK3—kidney cancer	1.36e-06	0.000128	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MYC—kidney cancer	1.32e-06	0.000124	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS2—kidney cancer	1.3e-06	0.000122	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK1—kidney cancer	1.29e-06	0.000121	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS2—kidney cancer	1.29e-06	0.000121	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTEN—kidney cancer	1.23e-06	0.000115	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KRAS—kidney cancer	1.22e-06	0.000115	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTEN—kidney cancer	1.2e-06	0.000113	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTEN—kidney cancer	1.13e-06	0.000106	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	1.12e-06	0.000105	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTEN—kidney cancer	1.12e-06	0.000105	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TP53—kidney cancer	1.09e-06	0.000102	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—POMC—kidney cancer	1.06e-06	9.97e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CA—kidney cancer	9.72e-07	9.12e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CA—kidney cancer	8.68e-07	8.14e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS2—kidney cancer	8.48e-07	7.95e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CA—kidney cancer	8.47e-07	7.94e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CA—kidney cancer	7.98e-07	7.48e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CA—kidney cancer	7.91e-07	7.42e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTEN—kidney cancer	7.4e-07	6.94e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CA—kidney cancer	5.22e-07	4.89e-05	CbGpPWpGaD
